426 related articles for article (PubMed ID: 33028364)
1. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas.
Mudassar F; Shen H; O'Neill G; Hau E
J Exp Clin Cancer Res; 2020 Oct; 39(1):208. PubMed ID: 33028364
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas.
Shen H; Cook K; Gee HE; Hau E
J Exp Clin Cancer Res; 2020 Jul; 39(1):129. PubMed ID: 32631383
[TBL] [Abstract][Full Text] [Related]
3. Targeting Glucose Metabolism of Cancer Cells with Dichloroacetate to Radiosensitize High-Grade Gliomas.
Cook KM; Shen H; McKelvey KJ; Gee HE; Hau E
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298883
[TBL] [Abstract][Full Text] [Related]
4. Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia.
Clarke RH; Moosa S; Anzivino M; Wang Y; Floyd DH; Purow BW; Lee KS
PLoS One; 2014; 9(10):e111199. PubMed ID: 25350400
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
Yang W; Wei J; Guo T; Shen Y; Liu F
Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
[TBL] [Abstract][Full Text] [Related]
6. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.
Hsieh CH; Lee CH; Liang JA; Yu CY; Shyu WC
Oncol Rep; 2010 Dec; 24(6):1629-36. PubMed ID: 21042761
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mitochondria NADH-Ubiquinone oxidoreductase (complex I) sensitizes the radioresistant glioma U87MG cells to radiation.
Gao X; Yang Y; Wang J; Zhang L; Sun C; Wang Y; Zhang J; Dong H; Zhang H; Gao C; Zhang B; Feng B; Mao W
Biomed Pharmacother; 2020 Sep; 129():110460. PubMed ID: 32768950
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Lon is over-expressed in high-grade gliomas, and mediates hypoxic adaptation: potential role of Lon as a therapeutic target in glioma.
Di K; Lomeli N; Wood SD; Vanderwal CD; Bota DA
Oncotarget; 2016 Nov; 7(47):77457-77467. PubMed ID: 27764809
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
Dhermain F
Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
[TBL] [Abstract][Full Text] [Related]
10. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors.
Mao XG; Yan M; Xue XY; Zhang X; Ren HG; Guo G; Wang P; Zhang W; Huo JL
Lab Invest; 2011 Jul; 91(7):1068-78. PubMed ID: 21483406
[TBL] [Abstract][Full Text] [Related]
12. Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions.
Bache M; Zschornak MP; Passin S; Kessler J; Wichmann H; Kappler M; Paschke R; Kaluđerović GN; Kommera H; Taubert H; Vordermark D
Radiat Oncol; 2011 Sep; 6():111. PubMed ID: 21906280
[TBL] [Abstract][Full Text] [Related]
13. Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells.
Short SC; Giampieri S; Worku M; Alcaide-German M; Sioftanos G; Bourne S; Lio KI; Shaked-Rabi M; Martindale C
Neuro Oncol; 2011 May; 13(5):487-99. PubMed ID: 21363882
[TBL] [Abstract][Full Text] [Related]
14. Development of a Hypoxic Radiosensitizer-Prodrug Liposome Delivery DNA Repair Inhibitor Dbait Combination with Radiotherapy for Glioma Therapy.
Liu H; Cai Y; Zhang Y; Xie Y; Qiu H; Hua L; Liu X; Li Y; Lu J; Zhang L; Yu R
Adv Healthc Mater; 2017 Jun; 6(12):. PubMed ID: 28371526
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro.
Wang W; Long L; Wang L; Tan C; Fei X; Chen L; Huang Q; Liang Z
Cancer Lett; 2016 Feb; 371(2):274-84. PubMed ID: 26706414
[TBL] [Abstract][Full Text] [Related]
16. Spinal cord stimulation as adjuvant during chemotherapy and reirradiation treatment of recurrent high-grade gliomas.
Clavo B; Robaina F; Jorge IJ; Cabrera R; Ruiz-Egea E; Szolna A; Otermin E; Llontop P; Carames MA; Santana-Rodríguez N; Sminia P
Integr Cancer Ther; 2014 Nov; 13(6):513-9. PubMed ID: 25228535
[TBL] [Abstract][Full Text] [Related]
17. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
[TBL] [Abstract][Full Text] [Related]
18. Radiation sensitivity of GL261 murine glioma model and enhanced radiation response by flavopiridol.
Newcomb EW; Lymberis SC; Lukyanov Y; Shao Y; Schnee T; Devitt M; Rosenstein BS; Zagzag D; Formenti SC
Cell Cycle; 2006 Jan; 5(1):93-9. PubMed ID: 16319534
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs involved in chemo- and radioresistance of high-grade gliomas.
Besse A; Sana J; Fadrus P; Slaby O
Tumour Biol; 2013 Aug; 34(4):1969-78. PubMed ID: 23568705
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy for glioma stem cells.
Rizzo AE; Yu JS
Adv Exp Med Biol; 2015; 853():85-110. PubMed ID: 25895709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]